Complete clinical response to neoadjuvant chemoradiation in rectal cancers: Can surgery be avoided?

Hepato-Gastroenterology

Volumn 60, Issue 123, 2013, Pages 410-414

  Seshadri, Ramakrishnan Ayloor ^a   Kondaveeti, Satish S ^a   Jayanand, Sunil Bhanu ^a   John, Alexander ^a   Rajendranath, Rejiv ^a   Arumugam, Vasanthan ^a   Ellusamy, Hemanth Raj ^a   Sagar, Tenali Gnana ^a  

^a CANCER INSTITUTE WIA   (India)

Author keywords

Complete response; Neoadjuvant chemoradiation; Outcomes; Rectal cancer; Surgery

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER CENTER; CANCER PATIENT; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ELECTIVE SURGERY; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MALE; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RECTUM CANCER; RECTUM HEMORRHAGE; TELANGIECTASIA; TERTIARY HEALTH CARE;

ADULT; AGED; CHEMORADIOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; PATIENT SELECTION; RECTAL NEOPLASMS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TERTIARY CARE CENTERS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84879592774     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge12354     Document Type: Article

References (33)

1. Sauer R, Becker H, Hohenberger W, et al.: Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Eng J Med 2004; 351:1731-1740.
2. Roh SM, Colangelo LH, O'Connell MJ, et al.: Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol 2009; 27:5124-5130.
3. Glynn-Jones R, Wallace M, Livingstone JIL, Meyrick-Thomas J: Complete clinical response after preoperative chemoradiation in rectal cancer: is a "wait and see" policy justified? Dis Colon Rectum 2008; 51:10-20.
4. Hartley A, Ho KF, Mc Conkey C, Geh JI: Pathological complete response following pre-operative chemoradiotherapy in rectal cancer: analysis of phase II/III trials Br J Radiol 2005; 78:934-938. (Pubitemid 41582245)
5. Mohiuddin M, Winter K, Mitchell E, et al.: Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group trial 0012. J Clin Oncol 2006; 24:650-655. (Pubitemid 46630429)
6. Quah HM, Chou JF, Gonen M, et al.: Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation. Cancer 2008; 113:57-64. (Pubitemid 351976386)
7. Caprici C, Valentini V, Cionini L, et al.: Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients. Int J Radiation Oncology Biol Phys 2008; 72:99-107.
8. Maas M, Nelemans PJ, Valentini V, et al.: Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol 2010; 11:835-844.
9. Chessin DB, Enker W, Cohen AM, et al.: Complications after preoperative combined modality therapy and radical resection of locally advanced rectal cancer: a 14-year experience from a specialty service. J Am Coll Surg 2005; 200:876-882. (Pubitemid 40744794)
10. Habr-Gama A, Perez RO, Nadalin W, et al.: Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 2004; 240:711-717.
11. Rossi B, Nakagawa W, Novaes P, Filho WD, Lopes A: Radiation and chemotherapy instead of surgery for low infiltrative rectal adenocarcinoma: a prospective trial. Ann Surg Oncol 1998; 5:113-118. (Pubitemid 29071279)
12. Nakagawa WT, Rossi BM, De Ferreira F, et al.: Chemoradiation instead of surgery to treat mid and low rectal tumors: is it safe? Ann Surg Oncol 2006; 9:568-573. (Pubitemid 34774418)
13. Hughes R, Harrison M, Glynne-Jones R: Could a wait and see policy be justified in T3/4 rectal cancers after chemo-radiotherapy? Acta Oncologica 2010; 49:378-381.
14. Den Dulk M, van de Velde CJH: Considerations and restrictions for non-operative treatment of rectal cancer in selected patients. Lancet Oncol 2007; 8:570-571.
15. Bujko K, Kepka L, Nowacki MP: Chemoradiotherapy alone for rectal cancer: a word of caution. Lancet Oncol 2007; 8:860-862. (Pubitemid 47488060)
16. nd European rectal cancer consensus conference (EURECA-CC2. Radiother Oncol 2009; 92:148-163.
17. Jayanand SB, Seshadri RA, Tapkire R: Signet ring cell histology and non-circumferential tumors predict pathological complete response following neoadjuvant chemoradiation in rectal cancers. Int J Colorectal Dis 2011; 26:23-27.
18. Wang Y, Cummins B, Catton P, et al.: Primary radical external beam radiotherapy of rectal adenocarcinoma: Long term outcome of 271 patients. Radiother Oncol 2005; 77:126-132. (Pubitemid 41682376)
19. Gerard JP, Chapet O, Ramaioli A, Romestaing P: Long-term control of T2-T3 rectal adenocarcinoma with radiotherapy alone. Int J Radiation Oncology Biol Phys 2002; 54:142-149.
20. Habr-Gama A, Perez RO, Proscurshim I, et al.: Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy. J Gastrointest Surg 2006; 10:1319-1328.
21. Maas M, Beets-Tan GH, Lambregts DMJ, et al.: Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol 2011; 29:4633-4640.
22. Francois Y, Nemoz CJ, Baulieux J, et al.: Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol 1999; 17:2396-2402. (Pubitemid 29368238)
23. Habr-Gama A, Perez RO, Proscurshim I, Gama-Rodridues J: Complete clinical response after neoadjuvant chemoradiation for distal rectal cancer. Surg Oncol Clin N Am 2010; 19:829-845.
24. Hiotis SP, Weber SM, Cohen AM, et al.: Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients. J Am Coll Surg 2002; 194:131-135.
25. Guillem JG, Chessin DB, Shia J, et al.: Clinical examination following preoperative chemoradiation for rectal cancer is not a reliable surrogate end-point. J Clin Oncol 2005; 23:3475-3479.
26. Maretto I, Pomerri F, Puciarelli S, et al.: The potential of restaging in the prediction of pathologic response after preoperative chemoradiotherapy for rectal cancer. Ann Surg Oncol 2007; 14:455-461. (Pubitemid 46175289)
27. Mezzi G, Arcidiacono PG, Carrara S, et al.: Endoscopic ultrasound and magnetic resonance imaging for re-staging rectal cancer after radiotherapy. World J Gastroenterol 2009; 15:5563-5567.
28. Lambregts DM, Vandecaveye V, Barbaro B, et al.: Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study. Ann Surg Oncol 2011; 18:2224-2231.
29. Denecke T, Rau B, Hoffmann KT, et al.: Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: is there a benefit in using functional imaging? Eur Radiol 2005; 15:1658-1666 (Pubitemid 41102362)
30. Moore HG, Gittleman AE, Minsky BD, et al.: Rate of pathological complete response with increased interval between preoperative combined modality therapy and rectal cancer resection. Dis Colon Rectum 2004; 47:279-286. (Pubitemid 38280578)
31. Habr-Gama A, Perez RO, Wynn G, et al.: Complete clinical response after neoadjuvant chemoradiation therapy for distal rectal cancer: characterization of clinical and endoscopic findings for standardization. Dis Colon Rectum 2010; 53:1692-1698.
32. Kusters M, Marijnen CAM, van de Velde CJH, et al.: Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial. Eur J Surg Oncol 2010; 36:470-476.
33. Coco C, Valentini V, Manno A, et al.: Long-term results after neoadjuvant radiochemotherapy for locally advanced resectable extraperitoneal rectal cancer. Dis Colon Rectum 2006; 49:311-318.